دورية أكاديمية

Sertraline and Alprazolam in the Treatment of Panic Disorder

التفاصيل البيبلوغرافية
العنوان: Sertraline and Alprazolam in the Treatment of Panic Disorder
المؤلفون: Saida Fišeković, Svjetlana Loga-Zec
المصدر: Biomolecules & Biomedicine, Vol 5, Iss 2 (2005)
بيانات النشر: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina, 2005.
سنة النشر: 2005
المجموعة: LCC:Biology (General)
مصطلحات موضوعية: panic disorders, SSRI, benzodiazepine, Biology (General), QH301-705.5
الوصف: A compared, 12 week, placebo controlled study, with fixed dose, outpatient study of patients diagnosed with panic disorder with and without agoraphobia according to ICD-10, was conducted to evaluate the efficacy and safety of sertraline and alprazolam. The study included 40 patients, divided in two groups. We evaluated number of ICD-10-defined panic attacks, agoraphobia and anticipatory anxiety. All patients were aged 18 year and older and were randomized to either sertraline or alprazolam. Sertraline applied in fixed doses of 20 mg/day and alprazolam in doses 1-1,5 mg/day significantly reduced the frequency of panic attacks in panic disorder patients, reduced symptoms of agoraphobia and anticipatory anxiety
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2831-0896
2831-090X
Relation: https://www.bjbms.org/ojs/index.php/bjbms/article/view/3292; https://doaj.org/toc/2831-0896; https://doaj.org/toc/2831-090X
DOI: 10.17305/bjbms.2005.3292
URL الوصول: https://doaj.org/article/2efebd5d296448a7834f197b24e83cb5
رقم الأكسشن: edsdoj.2efebd5d296448a7834f197b24e83cb5
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:28310896
2831090X
DOI:10.17305/bjbms.2005.3292